Digital Biomarkers using Augmented Reality in Alzheimer’s Disease

Time: 11:00 am
day: Conference Day One


Digital biomarkers hold tremendous potential in the early detection, monitoring, and management of Alzheimer's disease. This fireside chat will bring together experts in the field to discuss the latest advancements, opportunities, and challenges associated with using digital biomarkers, focusing on Altoida's innovative approach using augmented reality and machine learning. The panelists will explore the following topics:


  • How can digital neurological biomarkers can assess cognition in clinical trials
  • Use of digital biomarkers for early detection and diagnosis of Alzheimer's disease
  • Current applications of Altoida’s technology to support the advancement and adoption of digital biomarkers in Alzheimer's disease clinical trials
  • Digital biomarkers on Quality of Life measures
  • Challenges and opportunities for use of digital biomarkers in Alzheimer’s clinical trials